Dealing with uncertainty in the treatment of Helicobacter pylori
Author:
Open Access
- 12 February 2018
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 9 (4) , 93-102
Abstract
Helicobacter pylori treatment may be viewed as an uncertain situation, where current knowledge is insufficient to provide evidence-based recommendations for all possible scenarios. Evidence suggests that, under uncertainty conditions, a few simple rules of thumb tend to work better than complex algorithms. Overall, five evidence-based rules of thumb are suggested: (1) Use four drugs; (2) Use maximal acid inhibition; (3) Treat for 2 weeks; (4) Do not repeat antibiotics after treatment failure; and (5) If your treatment works locally, keep using it. These simple rules of thumb may help the reader to select the best alternative for a given patient, choosing between the heterogeneous recommendations provided by the many different consensus conferences on H. pylori treatment recently published.Keywords
This publication has 48 references indexed in Scilit:
- Meta-Analysis of Bismuth Quadruple Therapy versus Clarithromycin Triple Therapy for Empiric Primary Treatment of Helicobacter pylori InfectionDigestion, 2013
- Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pyloriClinical and Experimental Gastroenterology, 2012
- A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pyloriAmerican Journal of Gastroenterology, 2011
- Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enoughAlimentary Pharmacology & Therapeutics, 2011
- Helicobacter pyloriInfectionNew England Journal of Medicine, 2010
- Accuracy of Diagnostic Tests forHelicobacter pylori:A ReappraisalClinical Infectious Diseases, 2009
- Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradicationAlimentary Pharmacology & Therapeutics, 2008
- Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in CaucasiansBritish Journal of Clinical Pharmacology, 2008
- Evidence that the Degree and Duration of Acid Suppression are Related to Helicobacter pylori Eradication by Triple TherapyHelicobacter, 2007
- A meta‐analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infectionAlimentary Pharmacology & Therapeutics, 2000